Search form

Hologic Launches ThinPrep® 5000 Processor and ThinPrep 5000 with Autoloader System for Automated Processing of Gynecological Samples

-- Systems Increase Ease of Use and Productivity for Cytology Labs --                                

MARLBOROUGH, Mass., November 10, 2015 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that gynecological samples can now be processed on the ThinPrep 5000 Processor and the ThinPrep 5000 with Autoloader System, providing labs with state-of-the-art automation and productivity for preparing cytology slides. 

“Our launch of these two new ThinPrep processors provides customers access to the next generation in cytology slide processing,” said Tom West, Hologic’s Division President, Diagnostic Solutions.  “Each instrument provides significant improvements in customer convenience, and is an important addition to our portfolio of market-leading cytology products.”

The ThinPrep 5000 Processor is a benchtop unit designed to address specific customer needs, including walkaway automation for up to 20 slides per run.  It provides fully automated slide preparation, including automated capping and de-capping of ThinPrep vials, and chain of custody verification.  In addition, slides are directly output into stainer-ready racks. 

The ThinPrep 5000 with Autoloader System is designed for walkaway flexibility in processing.  The system provides continuous access to vials, consumables and processed slides for loading and unloading.  With a capacity of 160 samples in a single run, the ThinPrep 5000 with Autoloader System provides users up to eight hours of walkaway time.  It also provides laser slide etching of barcodes, which simplifies processing and helps ensure chain-of-custody.

The ThinPrep 5000 Processor and the ThinPrep 5000 with Autoloader System are both FDA approved for processing ThinPrep® Pap tests, as well as Non-Gyn and UroCyte® vials. 

About Hologic

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products.  The Company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health.  With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.  For more information, visit  

Hologic, Science of Sure, ThinPrep, UroCyte and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.

Forward-Looking Statements

This news release may contain forward‐looking information that involves risks and uncertainties, including statements about the use of the ThinPrep 5000 Processor and the ThinPrep 5000 with Autoloader System.  There can be no assurance that these products will achieve the benefits described herein, or that such benefits will be replicated in any particular manner with respect to any individual customer.  The actual effect of the use of the products can only be determined on a case‐by‐case basis depending on the particular circumstances and customer in question.  In addition, there can be no guarantee that these products will be adopted by customers or achieve any expected level of sales.  Hologic expressly disclaims any obligation to release publicly any updates or revisions to any such forward‐looking statements to reflect changes in expectations or in events, conditions or circumstances on which any such statements are based.


Michael Watts
Vice President, Investor Relations and Corporate Communications
(858) 410-8588